Although we cannot determine whether IGF-I will be effective in reverting more severe ataxia, as no effective treatments are available yet for this disease, and preliminary studies show beneficial effects of IGF-I in spinocerebellar ataxic patients [7], these results encourage its use in FRDA patients as well. Here, IGF1 is linked to cerebellar ataxia.